In this report, we describe a case of a 61-year-old male patient who had the bacterium growing in a blood culture. It was susceptible to ampicillin, ceftriaxone, levofloxacin, and vancomycin but was intermediately resistant to erythromycin. The patient did not have a negative outcome as a consequence of this bacterium, which retrospectively could have been predicted based on the epidemiological data within the patient's profile.
| Identifer | oai:union.ndltd.org:ETSU/oai:dc.etsu.edu:etsu-works-2-1133 |
| Date | 15 August 2020 |
| Creators | Sherret, John, Gajjar, Bhavesh, Ibrahim, Lamis, Elgazzar, Ahmed Mohamed, Panta, Utsab R. |
| Publisher | Digital Commons @ East Tennessee State University |
| Source Sets | East Tennessee State University |
| Detected Language | English |
| Type | text |
| Source | ETSU Faculty Works |
Page generated in 0.0022 seconds